Doctors expect to prescribe Sarepta’s DMD drug despite insurance concerns

(By Ed Silverman for STAT)

Definitive proof may be lacking that the newly approved¹ Duchenne muscular dystrophy actually works, but most neurologists expect to recommend the medicine for their patients, according to a new survey. Continue reading article here……

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.